[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Molecular Diagnostics Market - Global Outlook and Forecast 2021-2027

April 2021 | 108 pages | ID: C09BC5B46A96EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of COVID-19 Molecular Diagnostics in Global, including the following market information:

Global COVID-19 Molecular Diagnostics Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global COVID-19 Molecular Diagnostics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the COVID-19 Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global COVID-19 Molecular Diagnostics Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global COVID-19 Molecular Diagnostics Market Segment Percentages, By Type, 2020 (%)
  • High-throughput Sequencing
  • Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
  • Immunological Detection
China COVID-19 Molecular Diagnostics Market, By Application, 2016-2021, 2022-2027 ($ millions)

China COVID-19 Molecular Diagnostics Market Segment Percentages, By Application, 2020 (%)
  • Hospitals
  • Scientific Research
  • Biodiagnostics
Global COVID-19 Molecular Diagnostics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global COVID-19 Molecular Diagnostics Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total COVID-19 Molecular Diagnostics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total COVID-19 Molecular Diagnostics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Cellex
  • Abbott
  • Roche
  • BioMedomics
  • BD
  • Henry Schein
  • Safecare Bio-Tech
  • Thermo Fisher
  • Bio-rad
  • Agilent
  • Ortho Clinical Diagnostics
  • Zhejiang Orient Gene Biotech
  • Innovita Biological Technology
  • Guangzhou Wondfo Biotech
  • Guangdong Hecin-Scientific
  • Dynamiker Biotechnology (Tianjin)
  • ADVAITE
  • Mayo Clinic Laboratories
  • Chembio Diagnostics
  • Mount Sinai Laboratory
  • QIAGEN
  • Bioer
  • Biosynex
  • Esco
  • Analytik Jena
  • Techne
  • Da An Gene
  • BGI
  • Shanghai ZJ Bio-Tech
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 COVID-19 Molecular Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global COVID-19 Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COVID-19 MOLECULAR DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global COVID-19 Molecular Diagnostics Market Size: 2021 VS 2027
2.2 Global COVID-19 Molecular Diagnostics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top COVID-19 Molecular Diagnostics Players in Global Market
3.2 Top Global COVID-19 Molecular Diagnostics Companies Ranked by Revenue
3.3 Global COVID-19 Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 COVID-19 Molecular Diagnostics Companies in Global Market, by Revenue in 2020
3.5 Global Companies COVID-19 Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 COVID-19 Molecular Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 COVID-19 Molecular Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 COVID-19 Molecular Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global COVID-19 Molecular Diagnostics Market Size Markets, 2021 & 2027
  4.1.2 High-throughput Sequencing
  4.1.3 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
  4.1.4 Immunological Detection
4.2 By Type - Global COVID-19 Molecular Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global COVID-19 Molecular Diagnostics Revenue, 2016-2021
  4.2.2 By Type - Global COVID-19 Molecular Diagnostics Revenue, 2022-2027
  4.2.3 By Type - Global COVID-19 Molecular Diagnostics Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global COVID-19 Molecular Diagnostics Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Scientific Research
  5.1.4 Biodiagnostics
5.2 By Application - Global COVID-19 Molecular Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global COVID-19 Molecular Diagnostics Revenue, 2016-2021
  5.2.2 By Application - Global COVID-19 Molecular Diagnostics Revenue, 2022-2027
  5.2.3 By Application - Global COVID-19 Molecular Diagnostics Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global COVID-19 Molecular Diagnostics Market Size, 2021 & 2027
6.2 By Region - Global COVID-19 Molecular Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global COVID-19 Molecular Diagnostics Revenue, 2016-2021
  6.2.2 By Region - Global COVID-19 Molecular Diagnostics Revenue, 2022-2027
  6.2.3 By Region - Global COVID-19 Molecular Diagnostics Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America COVID-19 Molecular Diagnostics Revenue, 2016-2027
  6.3.2 US COVID-19 Molecular Diagnostics Market Size, 2016-2027
  6.3.3 Canada COVID-19 Molecular Diagnostics Market Size, 2016-2027
  6.3.4 Mexico COVID-19 Molecular Diagnostics Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe COVID-19 Molecular Diagnostics Revenue, 2016-2027
  6.4.2 Germany COVID-19 Molecular Diagnostics Market Size, 2016-2027
  6.4.3 France COVID-19 Molecular Diagnostics Market Size, 2016-2027
  6.4.4 U.K. COVID-19 Molecular Diagnostics Market Size, 2016-2027
  6.4.5 Italy COVID-19 Molecular Diagnostics Market Size, 2016-2027
  6.4.6 Russia COVID-19 Molecular Diagnostics Market Size, 2016-2027
  6.4.7 Nordic Countries COVID-19 Molecular Diagnostics Market Size, 2016-2027
  6.4.8 Benelux COVID-19 Molecular Diagnostics Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia COVID-19 Molecular Diagnostics Revenue, 2016-2027
  6.5.2 China COVID-19 Molecular Diagnostics Market Size, 2016-2027
  6.5.3 Japan COVID-19 Molecular Diagnostics Market Size, 2016-2027
  6.5.4 South Korea COVID-19 Molecular Diagnostics Market Size, 2016-2027
  6.5.5 Southeast Asia COVID-19 Molecular Diagnostics Market Size, 2016-2027
  6.5.6 India COVID-19 Molecular Diagnostics Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America COVID-19 Molecular Diagnostics Revenue, 2016-2027
  6.6.2 Brazil COVID-19 Molecular Diagnostics Market Size, 2016-2027
  6.6.3 Argentina COVID-19 Molecular Diagnostics Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa COVID-19 Molecular Diagnostics Revenue, 2016-2027
  6.7.2 Turkey COVID-19 Molecular Diagnostics Market Size, 2016-2027
  6.7.3 Israel COVID-19 Molecular Diagnostics Market Size, 2016-2027
  6.7.4 Saudi Arabia COVID-19 Molecular Diagnostics Market Size, 2016-2027
  6.7.5 UAE COVID-19 Molecular Diagnostics Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Cellex
  7.1.1 Cellex Corporate Summary
  7.1.2 Cellex Business Overview
  7.1.3 Cellex COVID-19 Molecular Diagnostics Major Product Offerings
  7.1.4 Cellex COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.1.5 Cellex Key News
7.2 Abbott
  7.2.1 Abbott Corporate Summary
  7.2.2 Abbott Business Overview
  7.2.3 Abbott COVID-19 Molecular Diagnostics Major Product Offerings
  7.2.4 Abbott COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.2.5 Abbott Key News
7.3 Roche
  7.3.1 Roche Corporate Summary
  7.3.2 Roche Business Overview
  7.3.3 Roche COVID-19 Molecular Diagnostics Major Product Offerings
  7.3.4 Roche COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.3.5 Roche Key News
7.4 BioMedomics
  7.4.1 BioMedomics Corporate Summary
  7.4.2 BioMedomics Business Overview
  7.4.3 BioMedomics COVID-19 Molecular Diagnostics Major Product Offerings
  7.4.4 BioMedomics COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.4.5 BioMedomics Key News
7.5 BD
  7.5.1 BD Corporate Summary
  7.5.2 BD Business Overview
  7.5.3 BD COVID-19 Molecular Diagnostics Major Product Offerings
  7.5.4 BD COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.5.5 BD Key News
7.6 Henry Schein
  7.6.1 Henry Schein Corporate Summary
  7.6.2 Henry Schein Business Overview
  7.6.3 Henry Schein COVID-19 Molecular Diagnostics Major Product Offerings
  7.6.4 Henry Schein COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.6.5 Henry Schein Key News
7.7 Safecare Bio-Tech
  7.7.1 Safecare Bio-Tech Corporate Summary
  7.7.2 Safecare Bio-Tech Business Overview
  7.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Major Product Offerings
  7.4.4 Safecare Bio-Tech COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.7.5 Safecare Bio-Tech Key News
7.8 Thermo Fisher
  7.8.1 Thermo Fisher Corporate Summary
  7.8.2 Thermo Fisher Business Overview
  7.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Major Product Offerings
  7.8.4 Thermo Fisher COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.8.5 Thermo Fisher Key News
7.9 Bio-rad
  7.9.1 Bio-rad Corporate Summary
  7.9.2 Bio-rad Business Overview
  7.9.3 Bio-rad COVID-19 Molecular Diagnostics Major Product Offerings
  7.9.4 Bio-rad COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.9.5 Bio-rad Key News
7.10 Agilent
  7.10.1 Agilent Corporate Summary
  7.10.2 Agilent Business Overview
  7.10.3 Agilent COVID-19 Molecular Diagnostics Major Product Offerings
  7.10.4 Agilent COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.10.5 Agilent Key News
7.11 Ortho Clinical Diagnostics
  7.11.1 Ortho Clinical Diagnostics Corporate Summary
  7.11.2 Ortho Clinical Diagnostics Business Overview
  7.11.3 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Major Product Offerings
  7.11.4 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.11.5 Ortho Clinical Diagnostics Key News
7.12 Zhejiang Orient Gene Biotech
  7.12.1 Zhejiang Orient Gene Biotech Corporate Summary
  7.12.2 Zhejiang Orient Gene Biotech Business Overview
  7.12.3 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Major Product Offerings
  7.12.4 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.12.5 Zhejiang Orient Gene Biotech Key News
7.13 Innovita Biological Technology
  7.13.1 Innovita Biological Technology Corporate Summary
  7.13.2 Innovita Biological Technology Business Overview
  7.13.3 Innovita Biological Technology COVID-19 Molecular Diagnostics Major Product Offerings
  7.13.4 Innovita Biological Technology COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.13.5 Innovita Biological Technology Key News
7.14 Guangzhou Wondfo Biotech
  7.14.1 Guangzhou Wondfo Biotech Corporate Summary
  7.14.2 Guangzhou Wondfo Biotech Business Overview
  7.14.3 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Major Product Offerings
  7.14.4 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.14.5 Guangzhou Wondfo Biotech Key News
7.15 Guangdong Hecin-Scientific
  7.15.1 Guangdong Hecin-Scientific Corporate Summary
  7.15.2 Guangdong Hecin-Scientific Business Overview
  7.15.3 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Major Product Offerings
  7.15.4 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.15.5 Guangdong Hecin-Scientific Key News
7.16 Dynamiker Biotechnology (Tianjin)
  7.16.1 Dynamiker Biotechnology (Tianjin) Corporate Summary
  7.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
  7.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Major Product Offerings
  7.16.4 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.16.5 Dynamiker Biotechnology (Tianjin) Key News
7.17 ADVAITE
  7.17.1 ADVAITE Corporate Summary
  7.17.2 ADVAITE Business Overview
  7.17.3 ADVAITE COVID-19 Molecular Diagnostics Major Product Offerings
  7.17.4 ADVAITE COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.17.5 ADVAITE Key News
7.18 Mayo Clinic Laboratories
  7.18.1 Mayo Clinic Laboratories Corporate Summary
  7.18.2 Mayo Clinic Laboratories Business Overview
  7.18.3 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Major Product Offerings
  7.18.4 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.18.5 Mayo Clinic Laboratories Key News
7.19 Chembio Diagnostics
  7.19.1 Chembio Diagnostics Corporate Summary
  7.19.2 Chembio Diagnostics Business Overview
  7.19.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Major Product Offerings
  7.19.4 Chembio Diagnostics COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.19.5 Chembio Diagnostics Key News
7.20 Mount Sinai Laboratory
  7.20.1 Mount Sinai Laboratory Corporate Summary
  7.20.2 Mount Sinai Laboratory Business Overview
  7.20.3 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Major Product Offerings
  7.20.4 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.20.5 Mount Sinai Laboratory Key News
7.21 QIAGEN
  7.21.1 QIAGEN Corporate Summary
  7.21.2 QIAGEN Business Overview
  7.21.3 QIAGEN COVID-19 Molecular Diagnostics Major Product Offerings
  7.21.4 QIAGEN COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.21.5 QIAGEN Key News
7.22 Bioer
  7.22.1 Bioer Corporate Summary
  7.22.2 Bioer Business Overview
  7.22.3 Bioer COVID-19 Molecular Diagnostics Major Product Offerings
  7.22.4 Bioer COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.22.5 Bioer Key News
7.23 Biosynex
  7.23.1 Biosynex Corporate Summary
  7.23.2 Biosynex Business Overview
  7.23.3 Biosynex COVID-19 Molecular Diagnostics Major Product Offerings
  7.23.4 Biosynex COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.23.5 Biosynex Key News
7.24 Esco
  7.24.1 Esco Corporate Summary
  7.24.2 Esco Business Overview
  7.24.3 Esco COVID-19 Molecular Diagnostics Major Product Offerings
  7.24.4 Esco COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.24.5 Esco Key News
7.25 Analytik Jena
  7.25.1 Analytik Jena Corporate Summary
  7.25.2 Analytik Jena Business Overview
  7.25.3 Analytik Jena COVID-19 Molecular Diagnostics Major Product Offerings
  7.25.4 Analytik Jena COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.25.5 Analytik Jena Key News
7.26 Techne
  7.26.1 Techne Corporate Summary
  7.26.2 Techne Business Overview
  7.26.3 Techne COVID-19 Molecular Diagnostics Major Product Offerings
  7.26.4 Techne COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.26.5 Techne Key News
7.27 Da An Gene
  7.27.1 Da An Gene Corporate Summary
  7.27.2 Da An Gene Business Overview
  7.27.3 Da An Gene COVID-19 Molecular Diagnostics Major Product Offerings
  7.27.4 Da An Gene COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.27.5 Da An Gene Key News
7.28 BGI
  7.28.1 BGI Corporate Summary
  7.28.2 BGI Business Overview
  7.28.3 BGI COVID-19 Molecular Diagnostics Major Product Offerings
  7.28.4 BGI COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.28.5 BGI Key News
7.29 Shanghai ZJ Bio-Tech
  7.29.1 Shanghai ZJ Bio-Tech Corporate Summary
  7.29.2 Shanghai ZJ Bio-Tech Business Overview
  7.29.3 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Major Product Offerings
  7.29.4 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Revenue in Global (2016-2021)
  7.29.5 Shanghai ZJ Bio-Tech Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. COVID-19 Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. COVID-19 Molecular Diagnostics Market Drivers in Global Market
Table 3. COVID-19 Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of COVID-19 Molecular Diagnostics in Global Market
Table 5. Top COVID-19 Molecular Diagnostics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global COVID-19 Molecular Diagnostics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global COVID-19 Molecular Diagnostics Revenue Share by Companies, 2016-2021
Table 8. Global Companies COVID-19 Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 COVID-19 Molecular Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 COVID-19 Molecular Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - COVID-19 Molecular Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - COVID-19 Molecular Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - COVID-19 Molecular Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - COVID-19 Molecular Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global COVID-19 Molecular Diagnostics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global COVID-19 Molecular Diagnostics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 30. Cellex Corporate Summary
Table 31. Cellex COVID-19 Molecular Diagnostics Product Offerings
Table 32. Cellex COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 33. Abbott Corporate Summary
Table 34. Abbott COVID-19 Molecular Diagnostics Product Offerings
Table 35. Abbott COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 36. Roche Corporate Summary
Table 37. Roche COVID-19 Molecular Diagnostics Product Offerings
Table 38. Roche COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 39. BioMedomics Corporate Summary
Table 40. BioMedomics COVID-19 Molecular Diagnostics Product Offerings
Table 41. BioMedomics COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 42. BD Corporate Summary
Table 43. BD COVID-19 Molecular Diagnostics Product Offerings
Table 44. BD COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 45. Henry Schein Corporate Summary
Table 46. Henry Schein COVID-19 Molecular Diagnostics Product Offerings
Table 47. Henry Schein COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 48. Safecare Bio-Tech Corporate Summary
Table 49. Safecare Bio-Tech COVID-19 Molecular Diagnostics Product Offerings
Table 50. Safecare Bio-Tech COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 51. Thermo Fisher Corporate Summary
Table 52. Thermo Fisher COVID-19 Molecular Diagnostics Product Offerings
Table 53. Thermo Fisher COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 54. Bio-rad Corporate Summary
Table 55. Bio-rad COVID-19 Molecular Diagnostics Product Offerings
Table 56. Bio-rad COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 57. Agilent Corporate Summary
Table 58. Agilent COVID-19 Molecular Diagnostics Product Offerings
Table 59. Agilent COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 60. Ortho Clinical Diagnostics Corporate Summary
Table 61. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product Offerings
Table 62. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 63. Zhejiang Orient Gene Biotech Corporate Summary
Table 64. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product Offerings
Table 65. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 66. Innovita Biological Technology Corporate Summary
Table 67. Innovita Biological Technology COVID-19 Molecular Diagnostics Product Offerings
Table 68. Innovita Biological Technology COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 69. Guangzhou Wondfo Biotech Corporate Summary
Table 70. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product Offerings
Table 71. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 72. Guangdong Hecin-Scientific Corporate Summary
Table 73. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product Offerings
Table 74. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 75. Dynamiker Biotechnology (Tianjin) Corporate Summary
Table 76. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product Offerings
Table 77. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 78. ADVAITE Corporate Summary
Table 79. ADVAITE COVID-19 Molecular Diagnostics Product Offerings
Table 80. ADVAITE COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 81. Mayo Clinic Laboratories Corporate Summary
Table 82. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product Offerings
Table 83. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 84. Chembio Diagnostics Corporate Summary
Table 85. Chembio Diagnostics COVID-19 Molecular Diagnostics Product Offerings
Table 86. Chembio Diagnostics COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 87. Mount Sinai Laboratory Corporate Summary
Table 88. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product Offerings
Table 89. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 90. QIAGEN Corporate Summary
Table 91. QIAGEN COVID-19 Molecular Diagnostics Product Offerings
Table 92. QIAGEN COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 93. Bioer Corporate Summary
Table 94. Bioer COVID-19 Molecular Diagnostics Product Offerings
Table 95. Bioer COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 96. Biosynex Corporate Summary
Table 97. Biosynex COVID-19 Molecular Diagnostics Product Offerings
Table 98. Biosynex COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 99. Esco Corporate Summary
Table 100. Esco COVID-19 Molecular Diagnostics Product Offerings
Table 101. Esco COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 102. Analytik Jena Corporate Summary
Table 103. Analytik Jena COVID-19 Molecular Diagnostics Product Offerings
Table 104. Analytik Jena COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 105. Techne Corporate Summary
Table 106. Techne COVID-19 Molecular Diagnostics Product Offerings
Table 107. Techne COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 108. Da An Gene Corporate Summary
Table 109. Da An Gene COVID-19 Molecular Diagnostics Product Offerings
Table 110. Da An Gene COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 111. BGI Corporate Summary
Table 112. BGI COVID-19 Molecular Diagnostics Product Offerings
Table 113. BGI COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 114. Shanghai ZJ Bio-Tech Corporate Summary
Table 115. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product Offerings
Table 116. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. COVID-19 Molecular Diagnostics Segment by Type
Figure 2. COVID-19 Molecular Diagnostics Segment by Application
Figure 3. Global COVID-19 Molecular Diagnostics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global COVID-19 Molecular Diagnostics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global COVID-19 Molecular Diagnostics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by COVID-19 Molecular Diagnostics Revenue in 2020
Figure 8. By Type - Global COVID-19 Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 9. By Application - Global COVID-19 Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 10. By Region - Global COVID-19 Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 11. By Country - North America COVID-19 Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 12. US COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe COVID-19 Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 16. Germany COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 17. France COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia COVID-19 Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 24. China COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 28. India COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America COVID-19 Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 30. Brazil COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa COVID-19 Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 33. Turkey COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE COVID-19 Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 37. Cellex COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Abbott COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Roche COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. BioMedomics COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. BD COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Henry Schein COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Safecare Bio-Tech COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Thermo Fisher COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Bio-rad COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Agilent COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Innovita Biological Technology COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. ADVAITE COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Chembio Diagnostics COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. QIAGEN COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 58. Bioer COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 59. Biosynex COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 60. Esco COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 61. Analytik Jena COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 62. Techne COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 63. Da An Gene COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 64. BGI COVID-19 Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications